Literature DB >> 4812148

Hepatitis B antigen in screened blood units for transfusion in renal dialysis patients.

W D Leers, G M Kouroupis.   

Abstract

Blood units for transfusion are screened routinely in Ontario for the presence of hepatitis B antigen (HB-Ag) by counter-immunoelectrophoresis (CIEP). Since the radioimmunoassay (RIA) method is more sensitive for this purpose we used it to test blood units delivered to the hospital's Renal Dialysis Unit in order to determine if HB-Ag-carrying blood donors were being missed by the less sensitive CIEP method.Out of the 606 blood units tested, eight were found to contain HB-Ag, an incidence of 13 out of 1000 donors. This finding indicates that the counter-immunoelectrophoresis method is insufficiently sensitive as a safe screening method for detection of hepatitis antigen.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812148      PMCID: PMC1947253     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Australia antigen in blood-donors.

Authors:  N A D'Amato
Journal:  Lancet       Date:  1973-04-21       Impact factor: 79.321

2.  Incidence of hepatitis B antigen and antibody among Canadian volunteer blood donors.

Authors:  B P Moore
Journal:  Can Med Assoc J       Date:  1972-09-09       Impact factor: 8.262

3.  Australin antigen detection. Comparison of results obtained with five CEP and one RIA test systems.

Authors:  J H Lewis; J E Coram
Journal:  Transfusion       Date:  1972 Sep-Oct       Impact factor: 3.157

4.  Dialysis-associated hepatitis: prevention and control.

Authors:  B J Hawe; H J Goldsmith; P O Jones
Journal:  Br Med J       Date:  1971-03-06

5.  Frequency of hepatitis B antigen in blood donors.

Authors:  D M Wrobel; V Feinman; B Berris; J Sinclair
Journal:  Can Med Assoc J       Date:  1973-03-03       Impact factor: 8.262

  5 in total
  3 in total

1.  Prevalence of hepatitis B antibodies in hospital personnel.

Authors:  W D Leers; G M Kouroupis
Journal:  Can Med Assoc J       Date:  1975-11-08       Impact factor: 8.262

2.  Letter: Hepatitis B antigen in screened blood units.

Authors: 
Journal:  Can Med Assoc J       Date:  1974-05-04       Impact factor: 8.262

3.  Occurrence of hepatitis and hepatitis B surface antigen in adult patients with acute leukemia.

Authors:  D H Cowan; G M Kouroupis; W D Leers
Journal:  Can Med Assoc J       Date:  1975-03-22       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.